Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

MULTIVAC Continues on its Successful Course

Hans-Joachim Boekstegers and Guido Spix, directors and CEO and CTO respectively of MULTIVAC, struck a consistently positive note at this year's press conference at IFFA.

This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.

Hans-Joachim Boekstegers and Guido Spix, directors and CEO and CTO respectively of MULTIVAC, struck a consistently positive note at this year's press conference at IFFA. In front of many journalists from home and abroad, they gave comprehensive details about the company's business development in the current year and a perspective on the strategic direction of the company. Highlighted on the exhibition stand were innovative packaging solutions and labelling and inspection systems for hand producers and industrial-scale meat processors.

MULTIVAC's figures can be clearly seen: the Group's turnover in 2015 was some 900 million euros. This equates to an increase of over 19 percent compared with the previous year. There are now 1,700 employees at its headquarters in Wolfertschwenden, and worldwide there are 4,700. With its own 75 sales and service companies, the Allgäu-based world market leader for packaging machines is now represented in over 140 countries.

Proof that MULTIVAC is also a leader in research and development is provided by the more than 300 patents, which the company has registered since 2002.

A new Logistics Center is currently under construction in Wolfertschwenden, and from the third quarter of this year onwards it will ensure that the production site is supplied with parts from its 5,400 m² warehouse, which will also supply European customers with genuine spare parts. And investment is also taking place at the Group's other sites. One example of this is a new production facility for manufacturing components in the Bulgarian town of Bozhurishte near Sofia, and the factory will be built by 2018 with a surface area of 20,000 m². The investment is around 19 million euros.

Despite low growth expectations for many sectors, Hans-Joachim Boekstegers and Guido Spix see great growth potential and opportunities for MULTIVAC. The growth markets will shift over the medium term from Europe and the USA to Asia, South America and Africa: “Even if for example uncertainty over the euro, price movements with raw materials, or devaluation of the Brazilian real or Russian rouble have a negative influence on the investment behaviour of companies, we are able as an internationally operating company to cope with the challenges,” says Hans-Joachim Boekstegers. “As an innovation and technology leader, we have very extensive know-how, which we systematically adapt to the requirements of customers and the market. Our starting position is therefore very good. But it will still remain challenging,” adds Guido Spix.

FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report